Advertisement
Review Article| Volume 39, ISSUE 1, P1-14, April 2023

Download started.

Ok

Rhodococcus equi–What is New This Decade?

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Equine Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Muscatello G.
        Rhodococcus equi pneumonia in the foal--part 1: pathogenesis and epidemiology.
        Vet J. 2012; 192: 20-26
        • Cohen N.D.
        Causes of and farm management factors associated with disease and death in foals.
        J Am Vet Med Assoc. 1994; 204: 1644-1651
        • Barton M.D.
        • Hughes K.L.
        Ecology of Rhodococcus equi.
        Vet Microbiol. 1984; 9: 65-76
        • Pusterla N.
        • Wilson W.D.
        • Mapes S.
        • et al.
        Diagnostic evaluation of real-time PCR in the detection of Rhodococcus equi in faeces and nasopharyngeal swabs from foals with pneumonia.
        Vet Rec. 2007; 161: 272-275
        • Chaffin M.K.
        • Cohen N.D.
        • Martens R.J.
        Evaluation of equine breeding farm characteristics as risk factors for development of Rhodococcus equi pneumonia in foals.
        J Am Vet Med Assoc. 2003; 222: 467-475
        • Muscatello G.
        • Gilkerson J.R.
        • Browning G.F.
        Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals.
        J Clin Microbiol. 2009; 47: 734-737
        • Cohen N.D.
        • Chaffin M.K.
        • Kuskie K.R.
        • et al.
        Association of perinatal exposure to airborne Rhodococcus equi with risk of pneumonia caused by R equi in foals.
        Am J Vet Res. 2013; 74: 102-109
        • Jain S.
        • Bloom B.R.
        • Hondalus M.K.
        Deletion of vapA encoding Virulence Associated Protein A attenuates the intracellular actinomycete Rhodococcus equi.
        Mol Microbiol. 2003; 50: 115-128
        • Aslam M.W.
        • Lau S.F.
        • Chin C.S.L.
        • et al.
        Clinicopathological and radiographic features in 40 cats diagnosed with pulmonary and cutaneous Rhodococcus equi infection (2012-2018).
        J Feline Med Surg. 2020; 22: 774-790
        • Lin W.V.
        • Kruse R.L.
        • Yang K.
        • et al.
        Diagnosis and management of pulmonary infection due to Rhodococcus equi.
        Clin Microbiol Infect. 2019; 25: 310-315
        • Bryan L.K.
        • Clark S.D.
        • Diaz-Delgado J.
        • et al.
        Rhodococcus equi Infections in Dogs.
        Vet Pathol. 2017; 54: 159-163
        • Kinne J.
        • Madarame H.
        • Takai S.
        • et al.
        Disseminated Rhodococcus equi infection in dromedary camels (Camelus dromedarius).
        Vet Microbiol. 2011; 149: 269-272
        • Vazquez-Boland J.A.
        • Giguere S.
        • Hapeshi A.
        • et al.
        Rhodococcus equi: the many facets of a pathogenic actinomycete.
        Vet Microbiol. 2013; 167: 9-33
      1. Slovis NM, McCracken JL, Mundy G. How to use thoracic ultrasound to screen foals for Rhodococcus equi at affected farms. . Paper presented at: American Association of Equine Practitioners Annual Conference2005; Lexington, KY

        • Horowitz M.L.
        • Cohen N.D.
        • Takai S.
        • et al.
        Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection.
        J Vet Intern Med. 2001; 15: 171-175
        • Sanz M.
        • Loynachan A.
        • Sun L.
        • et al.
        The effect of bacterial dose and foal age at challenge on Rhodococcus equi infection.
        Vet Microbiol. 2013; 167: 623-631
        • Cohen N.D.
        • Kuskie K.R.
        • Smith J.L.
        • et al.
        Association of airborne concentration of virulent Rhodococcus equi with location (stall versus paddock) and month (January through June) on 30 horse breeding farms in central Kentucky.
        Am J Vet Res. 2012; 73: 1603-1609
        • Hondalus M.K.
        Pathogenesis and virulence of Rhodococcus equi.
        Vet Microbiol. 1997; 56: 257-268
        • Phumoonna T.
        • Barton M.D.
        • Vanniasinkam T.
        • et al.
        Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice.
        Vaccine. 2008; 26: 2457-2465
        • Bordin A.I.
        • Gressler L.T.
        • Alexander E.R.C.
        • et al.
        Guinea pig infection with the intracellular pathogen Rhodococcus equi.
        Vet Microbiol. 2018; 215: 18-22
        • Gonzalez-Iglesias P.
        • Scortti M.
        • MacArthur I.
        • et al.
        Mouse lung infection model to assess Rhodococcus equi virulence and vaccine protection.
        Vet Microbiol. 2014; 172: 256-264
        • Venner M.
        • Rodiger A.
        • Laemmer M.
        • et al.
        Failure of antimicrobial therapy to accelerate spontaneous healing of subclinical pulmonary abscesses on a farm with endemic infections caused by Rhodococcus equi.
        Vet J. 2012; 192: 293-298
        • Leclere M.
        • Magdesian K.G.
        • Kass P.H.
        • et al.
        Comparison of the clinical, microbiological, radiological and haematological features of foals with pneumonia caused by Rhodococcus equi and other bacteria.
        Vet J. 2011; 187: 109-112
        • Venner M.
        • Astheimer K.
        • Lammer M.
        • et al.
        Efficacy of mass antimicrobial treatment of foals with subclinical pulmonary abscesses associated with Rhodococcus equi.
        J Vet Intern Med. 2013; 27: 171-176
        • Venner M.
        • Credner N.
        • Lammer M.
        • et al.
        Comparison of tulathromycin, azithromycin and azithromycin-rifampin for the treatment of mild pneumonia associated with Rhodococcus equi.
        Vet Rec. 2013; 173: 397
        • Reuss S.M.
        • Chaffin M.K.
        • Cohen N.D.
        Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987-2007).
        J Am Vet Med Assoc. 2009; 235: 855-863
        • Huber L.
        • Giguere S.
        • Berghaus L.J.
        • et al.
        Development of septic polysynovitis and uveitis in foals experimentally infected with Rhodococcus equi.
        PLoS One. 2018; 13: e0192655
        • Tarancon I.
        • Leiva M.
        • Jose-Cunilleras E.
        • et al.
        Ophthalmologic findings associated with Rhodococcus equi bronchopneumonia in foals.
        Vet Ophthalmol. 2019; 22: 660-665
        • Wilkes E.J.A.
        • Hughes K.L.
        • Kessell A.E.
        • et al.
        Successful management of multiple extrapulmonary complications associated with Rhodococcus equi pneumonia in a foal.
        Equine Vet Education. 2016; 4: 186-192
        • Johns I.C.
        • Desrochers A.
        • Wotman K.L.
        • et al.
        Presumed immune-mediated hemolytic anemia in two foals with Rhodococcus equi infection.
        J Vet Emerg Crit Care (San Antonio). 2011; 21: 273-278
        • Sweeney C.R.
        • Sweeney R.W.
        • Divers T.J.
        Rhodococcus-Equi Pneumonia in 48 Foals - Response to Antimicrobial Therapy.
        Vet Microbiol. 1987; 14: 329-336
        • Vitale V.
        • Sgorbini M.
        • Cuteri V.
        • et al.
        Cytological Findings in Bronchoalveolar Lavage Fluid of Foals With Pneumonia Caused by Rhodococcus equi and Other Bacteria.
        J Equine Vet Sci. 2019; 79: 9-12
        • Ramirez S.
        • Lester G.D.
        • Roberts G.R.
        Diagnostic contribution of thoracic ultrasonography in 17 foals with Rhodococcus equi pneumonia.
        Vet Radiol Ultrasound. 2004; 45: 172-176
        • Giguere S.
        • Hernandez J.
        • Gaskin J.
        • et al.
        Evaluation of white blood cell concentration, plasma fibrinogen concentration, and an agar gel immunodiffusion test for early identification of foals with Rhodococcus equi pneumonia.
        J Am Vet Med Assoc. 2003; 222: 775-781
      2. McCracken JL. Evaluation of white blood cell, fibrinogen, serum amyloid A adn ultrasonographic grade to refine a R. equi screening program. Paper presented at: 65th American Association of Equine Practitioners Annual Convention2019; Denver, CO.

        • Arnold-Lehna D.
        • Venner M.
        • Berghaus L.J.
        • et al.
        Changing policy to treat foals with Rhodococcus equi pneumonia in the later course of disease decreases antimicrobial usage without increasing mortality rate.
        Equine Vet J. 2020; 52: 531-537
        • Passamonti F.
        • Vardi D.M.
        • Stefanetti V.
        • et al.
        Rhodococcus equi pneumonia in foals: an assessment of the early diagnostic value of serum amyloid A and plasma fibrinogen concentrations in equine clinical practice.
        Vet J. 2015; 203: 211-218
        • Shaw S.D.
        • Cohen N.D.
        • Chaffin M.K.
        • et al.
        Estimating the Sensitivity and Specificity of Real-Time Quantitative PCR of Fecal Samples for Diagnosis of Rhodococcus equi Pneumonia in Foals.
        J Vet Intern Med. 2015; 29: 1712-1717
        • Sanz M.G.
        • Villarino N.
        • Ferreira-Oliveira A.
        • et al.
        VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.
        Vet Immunol Immunopathol. 2015; 164: 10-15
      3. McCranken JL, Slovis NM. Use of thoracic ultrasound for the prevention of Rhodococcus equi pneumonia on endemic farms. Paper presented at: American Association of Equine Practitioners Annual Conference2009; Las Vegas, Nevada.

        • Wetzig M.
        • Venner M.
        • Giguere S.
        Efficacy of the combination of doxycycline and azithromycin for the treatment of foals with mild to moderate bronchopneumonia.
        Equine Vet J. 2020; 52: 613-619
        • Stieler A.L.
        • Sanchez L.C.
        • Mallicote M.F.
        • et al.
        Macrolide-induced hyperthermia in foals: Role of impaired sweat responses.
        Equine Vet J. 2016; 48: 590-594
        • Stieler Stewart A.L.
        • Sanchez L.C.
        • Mallicote M.F.
        • et al.
        Effects of clarithromycin, azithromycin and rifampicin on terbutaline-induced sweating in foals.
        Equine Vet J. 2017; 49: 624-628
        • Baverud V.
        • Franklin A.
        • Gunnarsson A.
        • et al.
        Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia.
        Equine Vet J. 1998; 30: 482-488
        • Giguere S.
        • Berghaus L.J.
        • Lee E.A.
        Activity of 10 antimicrobial agents against intracellular Rhodococcus equi.
        Vet Microbiol. 2015; 178: 275-278
        • Giguere S.
        • Jordan L.M.
        • Glass K.
        • et al.
        Relationship of mixed bacterial infection to prognosis in foals with pneumonia caused by Rhodococcus equi.
        J Vet Intern Med. 2012; 26: 1443-1448
        • Peters J.
        • Block W.
        • Oswald S.
        • et al.
        Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals.
        Drug Metab Dispos. 2011; 39: 1643-1649
        • Berlin S.
        • Kirschbaum A.
        • Spieckermann L.
        • et al.
        Pharmacological indices and pulmonary distribution of rifampicin after repeated oral administration in healthy foals.
        Equine Vet J. 2017; 49: 618-623
        • Berlin S.
        • Spieckermann L.
        • Oswald S.
        • et al.
        Pharmacokinetics and Pulmonary Distribution of Clarithromycin and Rifampicin after Concomitant and Consecutive Administration in Foals.
        Mol Pharmacol. 2016; 13: 1089-1099
        • Burton A.J.
        • Giguere S.
        • Berghaus L.J.
        • et al.
        Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.
        Antimicrobial Agents Chemother. 2015; 59: 3633-3636
        • Giguere S.
        Treatment of Infections Caused by Rhodococcus equi.
        Vet Clin North Am Equine Pract. 2017; 33: 67-85
        • Goebel B.
        • Freise F.
        • Venner M.
        Comparison of the efficacy of rifampin/azithromycin and rifampin/tulathromycin for the treatment of foals affected with pneumonia.
        Equine Vet Education. 2022; 34: e73-e77
        • Rutenberg D.
        • Venner M.
        • Giguere S.
        Efficacy of Tulathromycin for the Treatment of Foals with Mild to Moderate Bronchopneumonia.
        J Vet Intern Med. 2017; 31: 901-906
        • Hildebrand F.
        • Venner M.
        • Giguere S.
        Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia.
        J Vet Intern Med. 2015; 29: 333-338
        • Hildebrand F.
        • Giguere S.
        • Venner M.
        Treatment with gamithromycin in foals with pneumonia: comparative efficacy and adverse effects of i.m. versus i.v. administration.
        Pferdeheilkunde. 2015; 31: 165-170
        • Giguere S.
        • Jacks S.
        • Roberts G.D.
        Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia.
        J Vet Intern Med. 2004; 18: 568-573
        • Berghaus L.J.
        • Giguere S.
        • Guldbech K.
        Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
        Vet Microbiol. 2013; 166: 670-675
        • Cohen N.D.
        • Giguere S.
        • Burton A.J.
        • et al.
        Use of Liposomal Gentamicin for Treatment of 5 Foals with Experimentally Induced Rhodococcus equi Pneumonia.
        J Vet Intern Med. 2016; 30: 322-325
        • Giguere S.
        • Cohen N.
        Controversies in therapy of infections caused by Rhodococcus equi in foals.
        Equine Vet Education. 2018; 30: 336-341
        • Burton A.J.
        • Giguere S.
        • Sturgill T.L.
        • et al.
        Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA.
        Emerg Infect Dis. 2013; 19: 282-285
        • Huber L.
        • Giguere S.
        • Cohen N.D.
        • et al.
        Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA.
        Vet Microbiol. 2019; 235: 243-247
        • Alvarez-Narvaez S.
        • Giguere S.
        • Cohen N.
        • et al.
        Spread of Multidrug-Resistant Rhodococcus equi, United States.
        Emerg Infect Dis. 2021; 27: 529-537
        • Huber L.
        • Giguere S.
        • Hart K.A.
        • et al.
        Association between antimicrobial treatment of subclinical pneumonia in foals and selection of macrolide- and rifampicin-resistant Rhodococcus equi strains at horse-breeding farms in central Kentucky.
        J Am Vet Med Assoc. 2021; 258: 648-653
        • Giguere S.
        • Lee E.
        • Williams E.
        • et al.
        Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
        J Am Vet Med Assoc. 2010; 237: 74-81
        • Huber L.
        • Giguere S.
        • Slovis N.M.
        • et al.
        Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
        Antimicrobial Agents Chemother. 2019; 63 (e01714–18)
        • Erol E.
        • Locke S.
        • Saied A.
        • et al.
        Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis.
        Vet Microbiol. 2020; 242: 108568
        • Asoh N.
        • Watanabe H.
        • Fines-Guyon M.
        • et al.
        Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand.
        J Clin Microbiol. 2003; 41: 2337-2340
        • Giguere S.
        • Berghaus L.J.
        • Willingham-Lane J.M.
        Antimicrobial Resistance in Rhodococcus equi.
        Microbiol Spectr. 2017; 5 (ARBA 0004-22016)
        • Alvarez-Narvaez S.
        • Giguere S.
        • Berghaus L.J.
        • et al.
        Horizontal Spread of Rhodococcus equi Macrolide Resistance Plasmid pRErm46 across Environmental Actinobacteria.
        Appl Environ Microbiol. 2020; 86 (e00108-20)
        • Gundelly P.
        • Suzuki Y.
        • Ribes J.A.
        • et al.
        Differences in Rhodococcus equi Infections Based on Immune Status and Antibiotic Susceptibility of Clinical Isolates in a Case Series of 12 Patients and Cases in the Literature.
        Biomed Res Int. 2016; 2016: 2737295
        • Cywes-Bentley C.
        • Rocha J.N.
        • Bordin A.I.
        • et al.
        Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi.
        PLoS Pathog. 2018; 14: e1007160
        • Giles C.
        • Vanniasinkam T.
        • Ndi S.
        • et al.
        Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development.
        Equine Vet J. 2015; 47: 510-518
        • Cesar F.B.
        Rhodococcus equi in the foal –improving diagnostic and prevention measures - theses and dissertations: veterinary sciences.
        2018 (Available at)
        • Cohen N.D.
        • Kahn S.K.
        • Cywes-Bentley C.
        • et al.
        Serum Antibody Activity against Poly-N-Acetyl Glucosamine (PNAG), but Not PNAG Vaccination Status, Is Associated with Protecting Newborn Foals against Intrabronchial Infection with Rhodococcus equi.
        Microbiol Spectr. 2021; 9: e0063821
        • Hooper-McGrevy K.E.
        • Wilkie B.N.
        • Prescott J.F.
        Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R.
        Equi Vaccin. 2005; 23: 5760-5767
        • Rocha J.N.
        • Cohen N.D.
        • Bordin A.I.
        • et al.
        Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.
        PLoS One. 2016; 11: e0148111
        • Becu T.
        • Polledo G.
        • Gaskin J.M.
        Immunoprophylaxis of Rhodococcus equi pneumonia in foals.
        Vet Microbiol. 1997; 56: 193-204
        • Caston S.S.
        • McClure S.R.
        • Martens R.J.
        • et al.
        Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals.
        Vet Ther. 2006; 7: 361-375
        • Madigan J.E.
        • Hietala S.
        • Muller N.
        Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma.
        J Reprod Fertil Suppl. 1991; 44: 571-578
        • Perkins G.A.
        • Yeager A.
        • Erb H.N.
        • et al.
        Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
        Vet Ther. 2002; 3: 334-346
        • Sanz M.G.
        • Loynachan A.
        • Horohov D.W.
        Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals.
        Vet Rec. 2016; 178: 261
        • Kahn S.K.
        • Cywes-Bentley C.
        • Blodgett G.P.
        • et al.
        Randomized, controlled trial comparing Rhodococcus equi and poly-N-acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals.
        J Vet Intern Med. 2021; 35: 2912-2919
        • Kahn S.K.
        • Blodgett G.P.
        • Canaday N.M.
        • et al.
        Transfusion With 2 L of Hyperimmune Plasma is Superior to Transfusion of 1 L or Less for Protecting Foals Against Subclinical Pneumonia Attributed to Rhodococcus equi.
        J Equine Vet Sci. 2019; 79: 54-58
        • Flores-Ahlschwede P.
        • Kahn S.K.
        • Ahlschwede S.
        • et al.
        Transfusion with 2 litres of hyperimmune plasma is superior to transfusion of 1 litre for protecting foals against pneumonia attributed to Rhodococcus equi.
        Equine Vet J. 2021; 34: e67-e72
        • Sanz M.G.
        • Bradway D.S.
        • Horohov D.W.
        • et al.
        Rhodococcus equi-specific hyperimmune plasma administration decreases faecal shedding of pathogenic R. equi in foals.
        Vet Rec. 2019; 185: 19
        • Kahn S.K.
        • Cywes-Bentley C.
        • Blodgett G.P.
        • et al.
        Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia.
        PLoS One. 2021; 16: e0250133
        • Hardefeldt L.Y.
        • Keuler N.
        • Peek S.F.
        Incidence of transfusion reactions to commercial equine plasma.
        J Vet Emerg Crit Care (San Antonio). 2010; 20: 421-425
        • Sanz M.G.
        • Oliveira A.F.
        • Page A.
        • et al.
        Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals.
        Vet Rec. 2014; 175: 485